Promoter methylation status of hPer3 gene in AML patients and the in vitro effect of decitabine on the status
Zhonghua xue ye xue za zhi Zhonghua xueyexue zazhi (2011)
- PubMed: 21729600
Available from www.ncbi.nlm.nih.gov
or
Abstract
To investigate the clinical significance of promoter methylation status of hPer3 gene in acute myeloid leukemia (AML) patients and the in vitro effect of decitabine (DCA) on AML cell lines HL-60 and U937.
Sign up today - FREE
Mendeley saves you time finding and organizing research. Learn more
- All your research in one place
- Add and import papers easily
- Access it anywhere, anytime
Start using Mendeley in seconds!
Readership Statistics
Readership statistics are being calculated.